tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market
MBRX
Moleculin Biotech
RESEARCH TOOLSreports
Want to see MBRX full AI Analyst Report?

Moleculin Biotech (MBRX) Financial Statements

1,946 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently $13.18M. The company's EPS TTM is $-1746.42; its P/E ratio is 0.63; Moleculin Biotech is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -90.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -25.10M$ -26.64M$ -29.63M$ -30.64M$ -22.97M
EBITDA$ -25.01M$ -26.52M$ -29.50M$ -30.51M$ -22.80M
Net Income$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Balance Sheet
Cash & Short-Term Investments$ 8.88M$ 4.28M$ 23.55M$ 43.15M$ 70.90M
Total Assets$ 22.13M$ 16.93M$ 38.22M$ 57.42M$ 84.09M
Total Debt$ 359.00K$ 478.00K$ 574.00K$ 451.00K$ 159.00K
Net Debt$ -8.52M$ -3.80M$ -22.98M$ -42.69M$ -70.74M
Total Liabilities$ 7.12M$ 10.95M$ 12.14M$ 5.23M$ 5.10M
Stockholders' Equity$ 15.01M$ 5.98M$ 26.07M$ 52.19M$ 78.99M
Cash Flow
Free Cash Flow$ -22.73M$ -23.88M$ -24.23M$ -27.71M$ -18.97M
Operating Cash Flow$ -22.73M$ -23.86M$ -24.10M$ -27.64M$ -18.95M
Investing Cash Flow$ 0.00$ -13.00K$ -124.00K$ -67.00K$ -19.00K
Financing Cash Flow$ 27.28M$ 4.63M$ 4.65M$ -23.00K$ 74.72M
Currency in USD

Moleculin Biotech Earnings and Revenue History

Income Statement >

Moleculin Biotech Debt to Assets

Balance Sheet >

Moleculin Biotech Cash Flow

Cash Flow >

Moleculin Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >